Solid IO secures €800K to transform cancer treatment with tumour-on-chip technology
Solid IO secures €800K to transform cancer treatment with tumour-on-chip technology Solid IO, a pioneering medtech company specialising in patient-specific organ-on-chip technology, has successfully closed its first funding round of €800,000. The startup spun out of the University of Helsinki, has developed a tumour-on-chip platform that replicates the patient’s tumour